*Sponsored
StockWireNews
(Nasdaq: ISPC) Is Up Approx. 10% After Huge Breaking News Today (Low Float Under 1Mn Shares)
November 7th
Greetings Readers,
(Nasdaq: ISPC) is continuing to bring the heat after the opening bell.
As I mentioned in my previous correspondence, ISPC hit a high of $6.60 before the bell.
But now on the other side, ISPC could start turning heads quickly as it's up approx. 10% right now.
Don't forget. With a low float under 1Mn shares, volatility potential will need to be on high watch.
It's important to make note of ISPC's float because of this:
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9.5Mn Annually
From the article:
"Our mission has always been to connect researchers with the specimens they need to drive impactful advancements in healthcare," said Annette Arnold, Vice President of Sales and Business Development of iSpecimen. "With this expanded oncology biospecimen offering, we are empowering researchers around the world with access to critical resources that can fast-track their discoveries in cancer treatment and diagnostics to support life-saving treatments. We are also shortening lead times for order fulfillment which the Company expects to drive profitability for shareholders."
Consider (Nasdaq: ISPC) for your radar this morning and check out the full report below.
-----
My November kick-off profile caught the breakout bug as it ran from a previous night's after hours close of $.435 all the way to a high of $.6702 one day later.
The resulting explosion of approximately 54% put that NYSE American profile in the recent champ category and had use focusing on a new breakout idea.
Popping-off with a move of approximately 66% intraday when I previously suggested it as a radar watch, this past champ displayed explosive potential.
And when you see this profile's float (under 1Mn shares), you'll understand why it again has top place on our watch-list going into Thursday's opening bell.
Drop what you're doing and consider putting this Nasdaq profile on your radar:
*iSpecimen Inc. (Nasdaq: ISPC)*
iSpecimen offers an online marketplace for human biospecimens, connecting scientists in commercial and non-pro-fit organizations with healthcare providers that have access to patients and specimens needed for medical discovery.
And several potential catalysts could create breakout buzz for ISPC. Check them out:
#1. - A Very Low Float Could Create A Volatile Scenario In Moments.
#2. - An Explosive Chart History Since Mid-September Needs To Be Taken Seriously.
#3. - Major Revenue Growth Announced For Q2 2024 (Increase of 76% YOY).
#4. - This Company Displays A Long Growth History That's Been Picking Up The Pace In Recent Years...
But more on those in a second...
Company Breakdown: iSpecimen Inc. (Nasdaq: ISPC)
iSpecimen was founded to address a critical challenge: how to efficiently connect life science researchers who need human biospecimens with the billions of specimens available in healthcare organizations worldwide.
Their ground-breaking iSpecimen Marketplace® aids in solving this problem, reinventing the biospecimen procurement process to help accelerate medical discovery.
No comments:
Post a Comment